ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 14th, 2017 • Emergent BioSolutions Inc. • Pharmaceutical preparations • New York
This Asset Purchase Agreement is made on July 14, 2017 (the "Execution Date"), by and between Sanofi Pasteur Biologics, LLC, a Delaware limited liability company ("SPB LLC") and Acambis Research Ltd., a private limited company incorporated under the laws of England and Wales ("Acambis" and together with SPB LLC, the "Seller"), and Emergent BioSolutions Inc., a Delaware corporation (the "Purchaser"). The Seller and the Purchaser are individually referred to as a "Party" and collectively as the "Parties."
